“…MT ratio is decreased in the temporal lobe and hippocampus of patients with AD independent from atrophy [9][10][11][12]14,17,18 ; is variably correlated with clinical severity, neuropsychological measurements, and disease duration [9][10][11][12] ; and appears capable to track progression of regional GM microstructural changes in AD. 18 MT ratio was also reported to be decreased in the whole brain, whole temporal lobe, or temporal lobe GM and WM in patients with amnestic MCI as compared with agematched healthy control subjects. 10,11,19,20 However, in 2 studies that compared the MT ratio with several parameters calculated with quantitative MT approach in the hippocampus, enthorinal cortex, insula, and temporal neocortex, the former delivered the worst performance in differentiating AD, MCI, or healthy control subjects.…”